A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)

NCT03374085 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

200

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Multiple Myeloma

Interventions

DRUG: CC-92480
DRUG: Dexamethasone

Sponsor

Celgene